• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mayo Clin Proc Innov Qual Outcomes . Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant Eras

tetano

Editor, Senior Moderator
Mayo Clin Proc Innov Qual Outcomes


. 2026 May 8;10(3):100721.
doi: 10.1016/j.mayocpiqo.2026.100721. eCollection 2026 Jun.
Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant Eras

James F Howick V[SUP] 1 [/SUP], Bernard J Gersh[SUP] 2 [/SUP], Christopher G Scott[SUP] 3 [/SUP], Alanna Chamberlain[SUP] 2 [/SUP], Brian Shapiro[SUP] 1 [/SUP], Christopher J McLeod[SUP] 1 [/SUP], Christoffel J van Niekerk[SUP] 1 [/SUP], Bryan Taylor[SUP] 1 [/SUP], DeLisa Fairweather[SUP] 1 [/SUP], Carlos Vergara Sanchez[SUP] 1 [/SUP], Matt Utset[SUP] 4 [/SUP], Ufuk Vardar[SUP] 1 [/SUP], Robert D McBane 2nd[SUP] 5 [/SUP], Claire Raphael[SUP] 2 [/SUP], Jack Kiernan[SUP] 3 [/SUP], Tahir Kafil[SUP] 2 [/SUP], Leslie T Cooper Jr[SUP] 1 [/SUP], John P Bois[SUP] 2 6 [/SUP]


Affiliations
Abstract

Objective: To define the timing and intensity of cardiovascular risk after severe acute respiratory syndrome coronavirus 2 infection across the pre-Delta, Delta, and Omicron eras.
Patients and methods: We conducted a population-based retrospective cohort study of 162,471 adults with severe acute respiratory syndrome coronavirus 2 infection from March 1, 2020 to December 31, 2023 using the Rochester Epidemiology Project, a medical records-linkage system covering a 27-county region in Minnesota and Wisconsin. Outcomes included major adverse cardiovascular events, thrombotic events, and dysrhythmias, identified using validated International Classification of Diseases, 10th Revision codes. Cumulative incidence accounted for the competing risk of death, and multivariable Cox regression assessed age- and variant-specific risk.
Results: Over a median follow-up of 1.9 years (interquartile range, 1.2-2.4 years), 4922 individuals experienced major adverse cardiovascular events. Risk was highest within 30 days after infection and declined thereafter (P<.0001). During this early hazard window, adults aged ≥80 years had substantially higher adjusted risk in the pre-Delta and Delta eras compared with Omicron (pre-Delta hazard ratio, 3.89 [95% CI, 3.17-4.77]; Delta hazard ratio, 2.91 [95% CI, 2.28-3.71]). Thrombotic events showed a similar early, age-dependent pattern, peaking during the pre-Delta and Delta eras. Early dysrhythmia rates rose steeply with age and peaked during the Delta era, exceeding 60 events per 1000 person-months among adults aged ≥80 years. Late dysrhythmia incidence was stable across eras, reflecting persistent age-related risk.
Conclusion: Cardiovascular events after corona virus disease 2019 infection clustered within the first 30 days, with variation by age and variant era. This early concentration, most pronounced among older adults during the pre-Delta and Delta eras, is supportive of a clinically relevant hazard window while distinguishing observed patterns from causal inference. These findings support targeted, time-sensitive cardiovascular monitoring in higher-risk populations.


 
Back
Top